{"id":2508,"date":"2025-06-17T16:14:27","date_gmt":"2025-06-17T08:14:27","guid":{"rendered":"https:\/\/www.kousai.vip\/?p=2508"},"modified":"2025-11-06T11:55:11","modified_gmt":"2025-11-06T03:55:11","slug":"2025-eha%ef%bc%9a%e6%81%92%e8%b5%9b%e7%94%9f%e7%89%a9ksd-101-dc%e7%96%ab%e8%8b%97%e7%aa%81%e7%a0%b4%e6%80%a7%e6%95%b0%e6%8d%ae%e4%ba%ae%e7%9b%b8%ef%bc%8c%e6%8b%93%e5%b1%95ebv%e8%a1%80%e6%b6%b2","status":"publish","type":"post","link":"https:\/\/www.kousai.vip\/en\/2025\/06\/2025-eha%ef%bc%9a%e6%81%92%e8%b5%9b%e7%94%9f%e7%89%a9ksd-101-dc%e7%96%ab%e8%8b%97%e7%aa%81%e7%a0%b4%e6%80%a7%e6%95%b0%e6%8d%ae%e4%ba%ae%e7%9b%b8%ef%bc%8c%e6%8b%93%e5%b1%95ebv%e8%a1%80%e6%b6%b2\/","title":{"rendered":"2025 EHA: Kousai Bio\u2019s KSD\u2011101 DC vaccine unveils breakthrough data, expanding new frontiers in EBV hematologic tumor therapy"},"content":{"rendered":"<section class=\"wp-block-themepark-block-themepark-area block_layout thempark-block undefined\" id=\"\" style=\"\" data-swiper-parallax=\"-700\"><div class=\"block_layout_in\" style=\"\">\n<div class=\"wp-block-column block_layout_in\">\n<h2 class=\"wp-block-heading has-text-align-center has-vivid-red-color has-text-color has-link-color has-x-large-font-size wp-elements-8778aed6d6f1472346a5793214bc4eae\">2025 EHA<\/h2>\n\n\n\n<p class=\"has-text-align-center has-vivid-red-color has-text-color has-link-color has-medium-font-size wp-elements-7422b6eb48231353f7845265dedd6409\"><strong>Hensel Biologics Italy - Milan<\/strong><\/p>\n<\/div>\n<\/div><div class=\"layout_badh\"><div class=\"PcOnly themepark-block_layout_ba lazyload swiper-lazy\" style=\"background-size:cover;\" data-background=\"http:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/05\/\u80cc\u666f\u7d20\u675001.png\"><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-themepark-block-themepark-area block_layout thempark-block undefined\" id=\"\" style=\"background-color:#f1efe9;\" data-swiper-parallax=\"-700\"><div class=\"block_layout_in\" style=\"\">\n<div class=\"wp-block-column block_layout_in\">\n<div class=\"wp-block-themepark-block-themepark-wright content-super-p\" style=\"font-size:18px;line-height:30px;text-indent:2em;padding:20px 10px;\">\n<div class=\"wp-block-column\">\n<p><strong>The 30th Annual Meeting of the European Hematology Association (EHA\u202f2025) was successfully held from June\u202f12 to 15 in Milan, Italy. As the premier global gathering in the field of hematology, EHA brought together world\u2011leading experts, scholars and industry pioneers to discuss the latest breakthroughs and future directions in the diagnosis and treatment of blood diseases.<\/strong><\/p>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_3921a7-75 .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_3921a7-75 .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_3921a7-75\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n\n<p>Amid this international academic feast, Kousai Bio, a distinguished representative of innovative biotechnology in China, took the spotlight for the second year in a row. The company presented the latest research results of its self\u2011developed core product \u2013 the Dendritic Cell (DC) vaccine platform KSD\u2011101. The positive data and unique therapeutic potential demonstrated across a range of EBV\u2011related lymphoproliferative disorders (EBV\u2011LPDs) attracted the attention of attending experts, underscoring the innovative strength of Chinese expertise at the forefront of immunotherapy for hematologic malignancies.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"http:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-01-1024x768.jpg\" alt=\"\" class=\"wp-image-2504\" style=\"width:703px;height:auto\" srcset=\"https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-01-1024x768.jpg 1024w, https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-01-300x225.jpg 300w, https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-01-768x576.jpg 768w, https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-01.jpg 1080w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_807ffa-ed .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_807ffa-ed .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_807ffa-ed\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n<style>.wp-block-kadence-advancedbtn.kb-btns2508_008205-5f{gap:var(--global-kb-gap-xs, 0.5rem );justify-content:center;align-items:center;}.kt-btns2508_008205-5f .kt-button{font-weight:normal;font-style:normal;}.kt-btns2508_008205-5f .kt-btn-wrap-0{margin-right:5px;}.wp-block-kadence-advancedbtn.kt-btns2508_008205-5f .kt-btn-wrap-0 .kt-button{color:#555555;border-color:#555555;}.wp-block-kadence-advancedbtn.kt-btns2508_008205-5f .kt-btn-wrap-0 .kt-button:hover, .wp-block-kadence-advancedbtn.kt-btns2508_008205-5f .kt-btn-wrap-0 .kt-button:focus{color:#ffffff;border-color:#444444;}.wp-block-kadence-advancedbtn.kt-btns2508_008205-5f .kt-btn-wrap-0 .kt-button::before{display:none;}.wp-block-kadence-advancedbtn.kt-btns2508_008205-5f .kt-btn-wrap-0 .kt-button:hover, .wp-block-kadence-advancedbtn.kt-btns2508_008205-5f .kt-btn-wrap-0 .kt-button:focus{background:#444444;}<\/style>\n<div class=\"wp-block-kadence-advancedbtn kb-buttons-wrap kb-btns2508_008205-5f\"><style>ul.menu .wp-block-kadence-advancedbtn .kb-btn2508_a88459-b4.kb-button{width:initial;}.wp-block-kadence-advancedbtn .kb-btn2508_a88459-b4.kb-button{color:#000000;background:#8ed1fc;}<\/style><span class=\"kb-button kt-button button kb-btn2508_a88459-b4 kt-btn-size-large kt-btn-width-type-auto kb-btn-global-fill kt-btn-has-text-true kt-btn-has-svg-false  wp-block-kadence-singlebtn\"><span class=\"kt-btn-inner-text\"><strong>KSD-101:<\/strong><br><strong>An Innovative Platform Breaking New Ground in EBV\u2011LPD Treatment<\/strong><\/span><\/span><\/div>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_73277a-7f .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_73277a-7f .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_73277a-7f\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n\n<p>Confronted with the clinical challenge posed by type\u2011II Epstein\u2011Barr virus latent infection\u2014characterized by pronounced immune evasion and a lack of standard therapies\u2014Kousai Bio\u2019s KSD\u2011101 platform shows great promise. At this year\u2019s EHA, Kousai Bio presented data from its ongoing Phase\u202fI clinical trial, which enrolled patients with various EBV\u2011LPD subtypes, including angioimmunoblastic T\u2011cell lymphoma (AITL), nasal\u2011type\/peripheral NK\/T\u2011cell lymphoma (ENKTL), chronic active EBV infection (CAEBV), EBV\u2011associated hemophagocytic lymphohistiocytosis (HLH), diffuse large B\u2011cell lymphoma (DLBCL), and Hodgkin lymphoma (HL).<\/p>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_9daa42-23 .kt-block-spacer{height:60px;}.wp-block-kadence-spacer.kt-block-spacer-2508_9daa42-23 .kt-divider{border-top-width:4px;border-top-color:#8ed1fc;width:90%;border-top-style:dotted;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_9daa42-23\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n<style>.kt-tabs-id2508_c96884-99 > .kt-tabs-content-wrap > .wp-block-kadence-tab{border-top:3px solid #0a6689;border-right:0px solid #0a6689;border-bottom:0px solid #0a6689;border-left:0px solid #0a6689;border-top-left-radius:0px;border-top-right-radius:0px;border-bottom-right-radius:0px;border-bottom-left-radius:0px;padding-top:var(--global-kb-spacing-sm, 1.5rem);padding-right:var(--global-kb-spacing-sm, 1.5rem);padding-bottom:var(--global-kb-spacing-sm, 1.5rem);padding-left:var(--global-kb-spacing-sm, 1.5rem);background:var(--global-palette9, #ffffff);}.wp-block-kadence-tabs .kt-tabs-id2508_c96884-99 > .kt-tabs-title-list li{margin-top:0px;margin-right:8px;margin-bottom:0px;margin-left:0px;}.wp-block-kadence-tabs .kt-tabs-id2508_c96884-99 > .kt-tabs-title-list li:last-child{margin-right:0px;}.wp-block-kadence-tabs .kt-tabs-id2508_c96884-99 > .kt-tabs-title-list li .kt-tab-title, .wp-block-kadence-tabs .kt-tabs-id2508_c96884-99 > .kt-tabs-content-wrap > .kt-tabs-accordion-title .kt-tab-title{line-height:1.4em;font-weight:regular;font-style:normal;border-top-width:0px;border-right-width:0px;border-bottom-width:0px;border-left-width:0px;border-top-left-radius:4px;border-top-right-radius:4px;border-bottom-right-radius:0px;border-bottom-left-radius:0px;padding-top:8px;padding-right:20px;padding-bottom:8px;padding-left:20px;border-color:var(--global-palette7, #eeeeee);}.wp-block-kadence-tabs .kt-tabs-id2508_c96884-99 > .kt-tabs-content-wrap > .kt-tabs-accordion-title .kt-tab-title{margin-top:0px;margin-right:8px;margin-bottom:0px;margin-left:0px;}.wp-block-kadence-tabs .kt-tabs-id2508_c96884-99 > .kt-tabs-title-list li .kt-tab-title:hover, .wp-block-kadence-tabs .kt-tabs-id2508_c96884-99 > .kt-tabs-content-wrap > .kt-tabs-accordion-title .kt-tab-title:hover{border-color:var(--global-palette7, #eeeeee);color:var(--global-palette3, #1A202C);background:var(--global-palette8, #F7FAFC);}.wp-block-kadence-tabs .kt-tabs-id2508_c96884-99 > .kt-tabs-title-list li.kt-tab-title-active .kt-tab-title, .wp-block-kadence-tabs .kt-tabs-id2508_c96884-99 > .kt-tabs-content-wrap > .kt-tabs-accordion-title.kt-tab-title-active .kt-tab-title{border-color:var(--global-palette7, #eeeeee);color:#000000;background:#8ed1fc;}@media all and (max-width: 1024px){.kt-tabs-id2508_c96884-99 > .kt-tabs-content-wrap > .wp-block-kadence-tab{border-top:3px solid #0a6689;border-right:0px solid #0a6689;border-bottom:0px solid #0a6689;border-left:0px solid #0a6689;}}@media all and (max-width: 767px){.kt-tabs-id2508_c96884-99 > .kt-tabs-content-wrap > .wp-block-kadence-tab{border-top:3px solid #0a6689;border-right:0px solid #0a6689;border-bottom:0px solid #0a6689;border-left:0px solid #0a6689;}}<\/style>\n<div class=\"wp-block-kadence-tabs alignnone\"><div class=\"kt-tabs-wrap kt-tabs-id2508_c96884-99 kt-tabs-has-1-tabs kt-active-tab-1 kt-tabs-layout-tabs kt-tabs-tablet-layout-inherit kt-tabs-mobile-layout-inherit kt-tab-alignment-left\"><ul class=\"kt-tabs-title-list\"><li id=\"tab-strongstrong\" class=\"kt-title-item kt-title-item-1 kt-tabs-svg-show-always kt-tabs-icon-side-right kt-tab-title-active\"><a href=\"#tab-strongstrong\" data-tab=\"1\" class=\"kt-tab-title kt-tab-title-1\"><span class=\"kt-title-text\"><strong>Promising Efficacy and Safety Profile<\/strong><\/span><\/a><\/li><\/ul><div class=\"kt-tabs-content-wrap\">\n<div class=\"wp-block-kadence-tab kt-tab-inner-content kt-inner-tab-1 kt-inner-tab39465f-30\"><div class=\"kt-tab-inner-content-inner\">\n<p><strong>Excellent safety<\/strong><\/p>\n\n\n\n<p>Treatment\u2011related adverse events (AEs) were predominantly mild (e.g., injection\u2011site reactions, fever, lymphadenopathy). No grade\u202f\u2265\u202f3 toxicities were observed, indicating good tolerability.<\/p>\n\n\n\n<p><strong>Established Recommended Dose<\/strong><\/p>\n\n\n\n<p>Based on trial data, the recommended Phase\u202fII clinical dose (RP2D) is set at 5\u202f\u00d7\u202f10\u2076 DCs per administration.<\/p>\n\n\n\n<p><strong>Encouraging Preliminary Efficacy<\/strong><\/p>\n\n\n\n<p>At a median follow\u2011up of 42.7\u202fweeks, the study demonstrated that KSD\u2011101 treatment led to notable disease remission, with the majority of patients achieving complete remission (CR) that was maintained over time.<\/p>\n\n\n\n<p><strong>Validation of Immunological Mechanism<\/strong><\/p>\n\n\n\n<p>The study observed that LMP2\u2011specific CD8\u207a T\u2011cell responses peaked at week\u202f6 post\u2011vaccination, accompanied by a decline in EBV DNA levels and a significant reduction in regulatory T cells (Tregs), strongly supporting the mechanism of action of KSD\u2011101.<\/p>\n<\/div><\/div>\n<\/div><\/div><\/div>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_c4cf96-e8 .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_c4cf96-e8 .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_c4cf96-e8\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n<style>.kt-tabs-id2508_23126f-71 > .kt-tabs-content-wrap > .wp-block-kadence-tab{border-top:3px solid #0a6689;border-right:0px solid #0a6689;border-bottom:0px solid #0a6689;border-left:0px solid #0a6689;border-top-left-radius:0px;border-top-right-radius:0px;border-bottom-right-radius:0px;border-bottom-left-radius:0px;padding-top:var(--global-kb-spacing-sm, 1.5rem);padding-right:var(--global-kb-spacing-sm, 1.5rem);padding-bottom:var(--global-kb-spacing-sm, 1.5rem);padding-left:var(--global-kb-spacing-sm, 1.5rem);background:var(--global-palette9, #ffffff);}.wp-block-kadence-tabs .kt-tabs-id2508_23126f-71 > .kt-tabs-title-list li{margin-top:0px;margin-right:8px;margin-bottom:0px;margin-left:0px;}.wp-block-kadence-tabs .kt-tabs-id2508_23126f-71 > .kt-tabs-title-list li:last-child{margin-right:0px;}.wp-block-kadence-tabs .kt-tabs-id2508_23126f-71 > .kt-tabs-title-list li .kt-tab-title, .wp-block-kadence-tabs .kt-tabs-id2508_23126f-71 > .kt-tabs-content-wrap > .kt-tabs-accordion-title .kt-tab-title{line-height:1.4em;font-weight:regular;font-style:normal;border-top-width:0px;border-right-width:0px;border-bottom-width:0px;border-left-width:0px;border-top-left-radius:4px;border-top-right-radius:4px;border-bottom-right-radius:0px;border-bottom-left-radius:0px;padding-top:8px;padding-right:20px;padding-bottom:8px;padding-left:20px;border-color:var(--global-palette7, #eeeeee);background:var(--global-palette7, #eeeeee);}.wp-block-kadence-tabs .kt-tabs-id2508_23126f-71 > .kt-tabs-content-wrap > .kt-tabs-accordion-title .kt-tab-title{margin-top:0px;margin-right:8px;margin-bottom:0px;margin-left:0px;}.wp-block-kadence-tabs .kt-tabs-id2508_23126f-71 > .kt-tabs-title-list li .kt-tab-title:hover, .wp-block-kadence-tabs .kt-tabs-id2508_23126f-71 > .kt-tabs-content-wrap > .kt-tabs-accordion-title .kt-tab-title:hover{border-color:var(--global-palette7, #eeeeee);color:var(--global-palette3, #1A202C);background:var(--global-palette8, #F7FAFC);}.wp-block-kadence-tabs .kt-tabs-id2508_23126f-71 > .kt-tabs-title-list li.kt-tab-title-active .kt-tab-title, .wp-block-kadence-tabs .kt-tabs-id2508_23126f-71 > .kt-tabs-content-wrap > .kt-tabs-accordion-title.kt-tab-title-active .kt-tab-title{border-color:var(--global-palette7, #eeeeee);color:#000000;background:#8ed1fc;}@media all and (max-width: 1024px){.kt-tabs-id2508_23126f-71 > .kt-tabs-content-wrap > .wp-block-kadence-tab{border-top:3px solid #0a6689;border-right:0px solid #0a6689;border-bottom:0px solid #0a6689;border-left:0px solid #0a6689;}}@media all and (max-width: 767px){.kt-tabs-id2508_23126f-71 > .kt-tabs-content-wrap > .wp-block-kadence-tab{border-top:3px solid #0a6689;border-right:0px solid #0a6689;border-bottom:0px solid #0a6689;border-left:0px solid #0a6689;}}<\/style>\n<div class=\"wp-block-kadence-tabs alignnone\"><div class=\"kt-tabs-wrap kt-tabs-id2508_23126f-71 kt-tabs-has-1-tabs kt-active-tab-1 kt-tabs-layout-tabs kt-tabs-tablet-layout-inherit kt-tabs-mobile-layout-inherit kt-tab-alignment-left\"><ul class=\"kt-tabs-title-list\"><li id=\"tab-strongstrongdcstrongstrong\" class=\"kt-title-item kt-title-item-1 kt-tabs-svg-show-always kt-tabs-icon-side-right kt-tab-title-active\"><a href=\"#tab-strongstrongdcstrongstrong\" data-tab=\"1\" class=\"kt-tab-title kt-tab-title-1\"><span class=\"kt-title-text\"><strong><strong>Technical Advantage: Establishing a New Paradigm for Multi\u2011Antigen DC Vaccines<\/strong><\/strong><\/span><\/a><\/li><\/ul><div class=\"kt-tabs-content-wrap\">\n<div class=\"wp-block-kadence-tab kt-tab-inner-content kt-inner-tab-1 kt-inner-tab925408-37\"><div class=\"kt-tab-inner-content-inner\">\n<p><strong>The core breakthrough of KSD\u2011101 lies in its innovative design concept:<\/strong><\/p>\n\n\n\n<p>1.<strong>Overcoming HLA restriction and antigen singularity<\/strong>:  Autologous dendritic cells are loaded with EBV\u2011related tumor composite antigens, enabling effective presentation of multiple viral epitopes, including LMP2 and EBNA1, thereby markedly expanding the scope of immune recognition.<\/p>\n\n\n\n<p>2.<strong>Inducing potent, synergistic immune responses<\/strong>:  The design simultaneously activates CD4\u207a helper T cells and CD8\u207a cytotoxic T cells, aiming to generate a more comprehensive and powerful antiviral and antitumor immune response.<\/p>\n\n\n\n<p>3.<strong>Immense platform potential<\/strong>: The underlying technology is highly extensible, providing a solid foundation for future expansion to other virus\u2011driven malignancies such as HPV\u2011associated head\u2011and\u2011neck cancers, HBV\u2011related liver cancer, KSHV\u2011associated hematologic tumors, and more.<\/p>\n<\/div><\/div>\n<\/div><\/div><\/div>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_b618d2-87 .kt-block-spacer{height:60px;}.wp-block-kadence-spacer.kt-block-spacer-2508_b618d2-87 .kt-divider{border-top-width:4px;border-top-color:#8ed1fc;width:90%;border-top-style:dotted;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_b618d2-87\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n<style>.wp-block-kadence-advancedbtn.kb-btns2508_a7669b-8a{gap:var(--global-kb-gap-xs, 0.5rem );justify-content:center;align-items:center;}.kt-btns2508_a7669b-8a .kt-button{font-weight:normal;font-style:normal;}.kt-btns2508_a7669b-8a .kt-btn-wrap-0{margin-right:5px;}.wp-block-kadence-advancedbtn.kt-btns2508_a7669b-8a .kt-btn-wrap-0 .kt-button{color:#555555;border-color:#555555;}.wp-block-kadence-advancedbtn.kt-btns2508_a7669b-8a .kt-btn-wrap-0 .kt-button:hover, .wp-block-kadence-advancedbtn.kt-btns2508_a7669b-8a .kt-btn-wrap-0 .kt-button:focus{color:#ffffff;border-color:#444444;}.wp-block-kadence-advancedbtn.kt-btns2508_a7669b-8a .kt-btn-wrap-0 .kt-button::before{display:none;}.wp-block-kadence-advancedbtn.kt-btns2508_a7669b-8a .kt-btn-wrap-0 .kt-button:hover, .wp-block-kadence-advancedbtn.kt-btns2508_a7669b-8a .kt-btn-wrap-0 .kt-button:focus{background:#444444;}<\/style>\n<div class=\"wp-block-kadence-advancedbtn kb-buttons-wrap kb-btns2508_a7669b-8a\"><style>ul.menu .wp-block-kadence-advancedbtn .kb-btn2508_bb57ef-52.kb-button{width:initial;}.wp-block-kadence-advancedbtn .kb-btn2508_bb57ef-52.kb-button{color:#000000;background:#8ed1fc;}<\/style><span class=\"kb-button kt-button button kb-btn2508_bb57ef-52 kt-btn-size-large kt-btn-width-type-auto kb-btn-global-fill kt-btn-has-text-true kt-btn-has-svg-false  wp-block-kadence-singlebtn\"><span class=\"kt-btn-inner-text\"><strong>Chinese Wisdom, Global Vision:<\/strong><br><strong>Accelerating Clinical Translation and International Expansion<\/strong><\/span><\/span><\/div>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_8c86b1-e1 .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_8c86b1-e1 .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_8c86b1-e1\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n\n<p>The clinical data led by Prof. Li Chunrui of the Department of Hematology, Tongji Hospital (affiliated with Tongji Medical College, Huazhong University of Science and Technology), sparked strong interest among international clinical experts at the EHA meeting.\u202fKousai\u202fBio\u2019s team engaged in active discussions with specialists from Europe, the Americas and Asia on the progress of KSD\u2011101, its therapeutic\u2011indication potential, immune\u2011mechanism exploration, preliminary efficacy and safety data, and future clinical development directions<\/p>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_4b45ce-22 .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_4b45ce-22 .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_4b45ce-22\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"766\" src=\"http:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-02-1024x766.jpg\" alt=\"\" class=\"wp-image-2505\" style=\"width:729px;height:auto\" srcset=\"https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-02-1024x766.jpg 1024w, https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-02-300x224.jpg 300w, https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-02-768x575.jpg 768w, https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-02.jpg 1080w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_1fadb8-de .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_1fadb8-de .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_1fadb8-de\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n\n<p>Dr. Liu Huining, Founder and Chief Scientific Officer of Kousai\u202fBio, and Mr. Chen Wei, Business Director, led the core team at the conference. Leveraging this global platform, the company consulted top worldwide experts on KSD\u2011101\u2019s future development strategy, clinical\u2011pathway optimization (based on the RP2D identified in Phase\u202fI), and potential international collaborations. Kousai\u202fBio is committed to accelerating the global development of this China\u2011originated therapy so that patients worldwide can benefit<\/p>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_430fec-34 .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_430fec-34 .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_430fec-34\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-large is-resized\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"768\" src=\"http:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-03-1024x768.jpg\" alt=\"\" class=\"wp-image-2506\" style=\"width:738px;height:auto\" srcset=\"https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-03-1024x768.jpg 1024w, https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-03-300x225.jpg 300w, https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-03-768x576.jpg 768w, https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-03.jpg 1080w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure><\/div>\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_ed33f3-23 .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_ed33f3-23 .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_ed33f3-23\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n<style>.wp-block-kadence-advancedbtn.kb-btns2508_685a11-f5{gap:var(--global-kb-gap-xs, 0.5rem );justify-content:center;align-items:center;}.kt-btns2508_685a11-f5 .kt-button{font-weight:normal;font-style:normal;}.kt-btns2508_685a11-f5 .kt-btn-wrap-0{margin-right:5px;}.wp-block-kadence-advancedbtn.kt-btns2508_685a11-f5 .kt-btn-wrap-0 .kt-button{color:#555555;border-color:#555555;}.wp-block-kadence-advancedbtn.kt-btns2508_685a11-f5 .kt-btn-wrap-0 .kt-button:hover, .wp-block-kadence-advancedbtn.kt-btns2508_685a11-f5 .kt-btn-wrap-0 .kt-button:focus{color:#ffffff;border-color:#444444;}.wp-block-kadence-advancedbtn.kt-btns2508_685a11-f5 .kt-btn-wrap-0 .kt-button::before{display:none;}.wp-block-kadence-advancedbtn.kt-btns2508_685a11-f5 .kt-btn-wrap-0 .kt-button:hover, .wp-block-kadence-advancedbtn.kt-btns2508_685a11-f5 .kt-btn-wrap-0 .kt-button:focus{background:#444444;}<\/style>\n<div class=\"wp-block-kadence-advancedbtn kb-buttons-wrap kb-btns2508_685a11-f5\"><style>ul.menu .wp-block-kadence-advancedbtn .kb-btn2508_d8699c-95.kb-button{width:initial;}.wp-block-kadence-advancedbtn .kb-btn2508_d8699c-95.kb-button{color:#000000;background:#8ed1fc;}<\/style><span class=\"kb-button kt-button button kb-btn2508_d8699c-95 kt-btn-size-large kt-btn-width-type-auto kb-btn-global-fill kt-btn-has-text-true kt-btn-has-svg-false  wp-block-kadence-singlebtn\"><span class=\"kt-btn-inner-text\"><strong>Looking Ahead:<\/strong><br><strong>Deepening Immunotherapy, Fulfilling Patient Commitments<\/strong><\/span><\/span><\/div>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_9a81cc-51 .kt-block-spacer{height:20px;}.wp-block-kadence-spacer.kt-block-spacer-2508_9a81cc-51 .kt-divider{border-top-width:1px;height:1px;border-top-color:#eee;width:80%;border-top-style:solid;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_9a81cc-51\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n\n<p>Kousai\u202fBio consistently upholds a \u201cpatient\u2011centered\u201d philosophy, focusing on unmet clinical needs in virus\u2011associated tumors. Ongoing development and optimization of the KSD\u2011101 platform\u2014particularly its favorable safety profile and early efficacy signals\u2014represent a pivotal step in translating basic mechanistic discoveries into clinical value. Going forward, Kousai\u202fBio will continue to invest in next\u2011generation immunotherapy products, expand its global partnership network, and integrate innovative outcomes into the worldwide health system, contributing Chinese strength to the reshaping of cancer treatment.<\/p>\n\n\n<style>.wp-block-kadence-spacer.kt-block-spacer-2508_3916b3-71 .kt-block-spacer{height:60px;}.wp-block-kadence-spacer.kt-block-spacer-2508_3916b3-71 .kt-divider{border-top-width:4px;border-top-color:#8ed1fc;width:90%;border-top-style:dotted;}<\/style>\n<div class=\"wp-block-kadence-spacer aligncenter kt-block-spacer-2508_3916b3-71\"><div class=\"kt-block-spacer kt-block-spacer-halign-center\"><hr class=\"kt-divider\"\/><\/div><\/div>\n\n\n\n<p class=\"has-text-align-center\"><strong>Kousai\u202fBio, driven by innovation, aspires to become a global pioneer and catalyst for precision immunotherapy in oncology.<\/strong><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div><div class=\"layout_badh\"><\/div><\/section>\n\n\n\n<p><\/p>\n\n\n\n<p><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":2504,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"themepark_post_bcolor":"#f5f5f5","themepark_post_width":"1022px","themepark_post_img":"","themepark_post_img_po":"left","themepark_post_img_re":false,"themepark_post_img_cover":false,"themepark_post_img_fixed":false,"themepark_post_hide_title":false,"themepark_post_main_b":"","themepark_post_main_p":100,"themepark_paddingblock":false,"footnotes":""},"categories":[10,3],"tags":[],"class_list":["post-2508","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-qy","category-news"],"metadata":{"_edit_lock":["1762507899:1"],"_edit_last":["1"],"views":["1116"],"_wp_old_date":["2025-06-18"],"_thumbnail_id":["2504"],"catce":["sidebar-widgets4"]},"medium_url":"https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-01-300x225.jpg","thumbnail_url":"https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-01-150x150.jpg","full_url":"https:\/\/www.kousai.vip\/wp-content\/uploads\/2025\/06\/2025EHA-01.jpg","_links":{"self":[{"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/posts\/2508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/comments?post=2508"}],"version-history":[{"count":0,"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/posts\/2508\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/media\/2504"}],"wp:attachment":[{"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/media?parent=2508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/categories?post=2508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.kousai.vip\/en\/wp-json\/wp\/v2\/tags?post=2508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}